Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ENB-106 by Ennovabio for Acute Renal Failure (ARF) (Acute Kidney Injury): Likelihood of Approval
ENB-106 is under clinical development by Ennovabio and currently in Phase III for Acute Renal Failure (ARF) (Acute Kidney Injury)....
Data Insights
ENB-106 by Ennovabio for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
ENB-106 is under clinical development by Ennovabio and currently in Phase III for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to GlobalData,...